Invivyd Inc. Secures $30M Loan from Silicon Valley Bank to Advance COVID-19 Antibody Development
Invivyd, Inc. has secured a $30 million non-dilutive loan facility with Silicon Valley Bank to support its research and development of COVID-19 treatments and prevention.
2 minutes to read